Bradford Capital Partners

Cohera Medical, Inc. is a medical device company specializing in the development of surgical adhesives and sealants for various surgical procedures. Founded in 2003 and based in Raleigh, North Carolina, the company offers innovative products such as TissuGlu, a biocompatible surgical adhesive designed for approximating tissue planes in abdominoplasty and other large flap surgeries, and Sylys, a synthetic surgical sealant aimed at reducing anastomotic leakage in gastrointestinal surgeries. TissuGlu is approved for use in the United States and the European Union, while Sylys has received CE Mark approval in Europe for specific applications. Cohera Medical's product line is grounded in a unique chemical design that promotes tissue healing and minimizes fluid accumulation, positioning the company to address various surgical needs across specialties, including plastic, general, and orthopedic surgery. The company continues to expand its portfolio with additional products in development, focusing on surgical mesh adhesives, hemostatic foams, and bone adhesives.